Searched for
PUNJAB BASED DRUGMAKER
Punjab drug body finds critical lapses at Jackson Laboratories' manufacturing facility in AmritsarThe Punjab FDA has taken decisive action by revoking the manufacturing licence of Jackson Laboratories in Amritsar due to severe regulatory...- India's Fortis to expand obesity clinics amid weight-loss therapy boom, CEO saysFortis Healthcare will expand its obesity clinic network. This decision follows increased demand for weight management solutions. Popular w...
- Punjab-based drugmaker asked to stop manufacturing after samples found to be of non-standard quality: GovtPunjab-based drugmaker QP Pharmachem Ltd has been directed to halt all manufacturing activity after the World Health Organisation (WHO) iss...
- India suspends another drugmaker's licence over tainted cough syrupIndia has suspended a drugmaker's manufacturing licence after the World Health Organization flagged contamination in its cough syrups found...
- Sun Pharma may shed part of Ranbaxy business to push growthFaced with disappointing revenue and profit going forward, Sun Pharma is mulling options of exiting Ranbaxy's "low-margin" overseas geograp...
- Sun Pharma may exit part of Ranbaxy business to push growthExiting the low-margin businesses may not result in a huge cash flow, but will improve the profitability of the company.
- Twelve stocks in focus in Tuesday's tradeIndian markets are expected to trade in a range. Here is a list of twelve stocks which are likely to remain in focus today.
- Ranbaxy suspends shipments of active ingredients from Toansa, Dewas plantsRanbaxy Laboratories said Tuesday it was suspending shipments from two of its plants following US import bans on its products over safety c...
- Ranbaxy recovers from fall; suspends shipments from two plantsReacting to the news, shares of the drug maker plunged as much as 2.3 per cent in trade on the BSE, but recouped early morning losses quick...
- Ranbaxy's Toansa plant under Indian drug regulator's watch tooIndia’s drug regulator has ordered Ranbaxy to furnish a comprehensive explanation for the violation of manufacturing practices at its Toans...
- Is Ranbaxy a contra buy? Stock slips 19% on USFDA import alertRanbaxy Laboratories Ltd plunged as much as 19.90 per cent in trade on Friday, after the US Food and Drug Administration import alert.
- Ranbaxy plunges 20% as USFDA halts drug imports from Toansa plantRanbaxy Labs plunged as much as 19.69% , after the USFDA ban effectively stops the company from shipping drugs from its Toansa plant.
- Ranbaxy starts generic Lipitor shipments from IndiaRanbaxy Laboratories Ltd has started exports of a copycat version of blockbuster cholesterol drug Lipitor from a new facility in India.
- Ranbaxy gets USFDA nod to sell LipitorThe approval marks an end to months of uncertainty surrounding approval of the drug which could earn Ranbaxy over $500 mn. Stock quote
- Ranbaxy may be allowed to sell Lipitor version in US; pay $350-400 million to settle outstanding issues with US FDARanbaxy and the US FDA are inching toward a settlement over the Indian drug maker’s regulatory troubles in the world’s largest drug market.
- Drug cos eye US entry after FDA checksThe US drug regulator has inspected the manufacturing plants of at least half-a-dozen Indian drugmakers, raising hopes that these companies...
- USFDA inspects Ranbaxy's new plant in MohaliThe USFDA did not respond to an e-mail query. The company's share price closed at 515.05, down 2.95% at the Bombay Stock Exchange on Wednes...
- Govt may make registration of drug brands mandatoryMove to help regulate brands to avoid duplication & confusion.
- Ranbaxy may wind up Mohali unitThe company sources products from local units now; may outsource manufacturing.
- Ranbaxy seeks to sell drugs from new Mohali plant in USRanbaxy Laboratories has filed for US Food and Drug Administration's (USFDA) approval to sell medicines from its upcoming manufacturing uni...
Load More
